| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 03/09/2005 | CN1592746A LFA-1 antagonist compounds |
| 03/09/2005 | CN1590372A Arylphenyl-substituted cyclic ketoenols |
| 03/09/2005 | CN1590357A Lightfast additive having uv-absorbing moiety and ink composition including the same |
| 03/09/2005 | CN1192020C Antidiabetic agents |
| 03/09/2005 | CN1192019C Cyclic amine derivatives |
| 03/09/2005 | CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 03/08/2005 | US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents |
| 03/08/2005 | US6864372 Process for the production of sulfonic esters |
| 03/08/2005 | US6864270 Iron binding agents |
| 03/08/2005 | US6864219 Substituted aryl ketones |
| 03/08/2005 | US6863722 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone by reductive amination of levulinic acid with nitro compounds |
| 03/03/2005 | WO2005019240A2 Melanin concentrating hormone receptor antagonists |
| 03/03/2005 | WO2005019168A2 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors |
| 03/03/2005 | WO2005019163A2 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 03/03/2005 | WO2005018635A2 Ion channel modulating activity i |
| 03/03/2005 | WO2005000309A3 Chemical compounds |
| 03/03/2005 | WO2004103309A3 Immunosuppressant compounds and compositions |
| 03/03/2005 | US20050049423 Production of 5-methyl-N-(methyl aryl)-2-pyrrolidone, 5-methyl-N-(methyl cycloalkyl)-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with cyano compounds |
| 03/03/2005 | US20050049406 Isotopically coded affinity markers 3 |
| 03/03/2005 | US20050049292 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression |
| 03/03/2005 | US20050049248 Method of use of the compound that includes a conjugated polyene with between 7 to 14 double bonds, and cyclohexene rings with ether, phosphate, sulfate, dextran or other group which imparts water solubility; cancer, rheumatoid arthritis, stroke, cardiovascular inflammation |
| 03/02/2005 | EP1510515A1 Phenylglycine derivatives as serine protease inhibitors |
| 03/02/2005 | EP1509500A1 Process for the preparation of the amorphous form of atorvastatin calcium salt |
| 03/02/2005 | EP1509499A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509495A1 Anilino liver x-receptor modulators |
| 03/02/2005 | EP1509213A2 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/02/2005 | EP1042279B1 Substituted beta-alanines |
| 03/02/2005 | EP0919553B1 cis-SUBSTITUTED AMINOCYCLOPROPANE DERIVATIVES |
| 03/02/2005 | CN1589260A Heterocyclic compounds and methods of use thereof |
| 03/02/2005 | CN1587252A Multiple photon absorptive phenyl fluorene derivative and its preparing method |
| 03/02/2005 | CN1191233C N-substituted nitrogen heterocyclic compound |
| 03/02/2005 | CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 03/01/2005 | US6861535 Cyclization method for the synthesis of pyrrolidine derivative compounds |
| 03/01/2005 | US6861445 3-Substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase |
| 03/01/2005 | US6861440 Antidiabetic agents |
| 03/01/2005 | US6861432 Piperazine derivatives that destabilize androgen receptors |
| 03/01/2005 | CA2368479C Method of producing 3,4-dehydroprolines and 3,4-dehydropiperidines |
| 02/24/2005 | WO2005016880A1 PROCESS FOR PRODUCTION OF cis-4-FLUORO-L-PROLINE DERIVATIVES |
| 02/24/2005 | WO2005016876A2 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016264A2 Diamine derivatives of quinone and uses thereof |
| 02/24/2005 | WO2005016242A2 Synthetic process for trans-aminocyclohexyl ether compounds |
| 02/24/2005 | US20050043558 Thiols and disulphides and their use in producing substrates |
| 02/24/2005 | US20050043547 Process for producing optically active azetidine-2-carboxylic acids |
| 02/24/2005 | US20050043546 protection of 1-(N-t-butoxycarbonyl)-4-aminomethylene-pyrrolidin-3-one with t-butoxycarbonyl anhydride, to afford 1-(N-t-butoxycarbonyl)-4-(N-t-butoxycarbonyl)aminomethylene-pyrrolidin-3-one, used as chemical intermediates for naphthyridine carboxylic acid derivatives having antibacterial activity |
| 02/24/2005 | US20050043397 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/24/2005 | US20050043392 Moderators of mnocyte chemoattractant protein; therapy for asthma; multiple sclerosis, antiarthritic agents, atherosclerosis |
| 02/24/2005 | US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants |
| 02/24/2005 | US20050043366 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage |
| 02/24/2005 | US20050043364 Novel pyrrole-based HMG-CoA reductase inhibitors |
| 02/24/2005 | US20050043354 Substance P antagonist |
| 02/24/2005 | US20050043320 Benzoylguanidine salt and hydrates thereof |
| 02/24/2005 | US20050043299 Inhibitors of dipeptidyl peptidase iv |
| 02/24/2005 | US20050043292 eg S)-[5-amino-6-oxo-6-(3,3,4,4-tetrafluoro-pyrrolidin-1-yl)-hexyl-carbamic acid benzylester; Type 2 diabetes, metabolic syndrome (syndrome X or insulin resistance syndrome), hyperglycemia, impaired glucose tolerance, glucosuria, metabolic acidosis, arthritis, cataracts, diabetic neuropathy |
| 02/24/2005 | US20050043290 for treating neurodegenerative disease such as Alzheimer's disease |
| 02/24/2005 | US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin |
| 02/24/2005 | US20050042614 Point mutations; dipeptidyl-peptidase inhibitors; kits |
| 02/24/2005 | US20050042188 A 4-hydroxy-L-proline alkyl ester; sunscreen agents |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2534950A1 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 02/24/2005 | CA2534884A1 Process for production of cis-4-fluoro-l-proline derivatives |
| 02/23/2005 | EP1508610A1 Lubricating oil additive composition for internal combustion engine |
| 02/23/2005 | EP1507757A1 Lactams used as anti-viral agents |
| 02/23/2005 | EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1585748A NK1 antagonists |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1585639A Antimalarial agents |
| 02/23/2005 | CN1583721A Synthesis of (S)-alpha-ethyl-2-oxi-1-pentazane acetamide |
| 02/23/2005 | CN1190419C Compound with electron providing and receiving functional groups |
| 02/23/2005 | CN1190418C Process for preparing distamycin derivatives |
| 02/23/2005 | CN1190406C Method for producing ortho-alkylated benzoic acid derivatives. |
| 02/22/2005 | US6858741 Use as pesticides and herbicides |
| 02/22/2005 | US6858740 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858637 Treating rheumatoid arthritis, psoriasis, cardiovascular disease, reperfusion injury, and bronchial asthma; e.g., 2-Methoxynaphthalene-1-carboxylic acid benzyl-indan-2-yl-amide |
| 02/22/2005 | US6858628 Substituted cyclic amine metalloprotease inhibitors |
| 02/22/2005 | US6858623 Amidino and guanidino peptidyl compounds |
| 02/22/2005 | US6858434 Using thin layer chromatography for rapid preparation and screening of lead structures for drug candidates; rational drug design |
| 02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 02/17/2005 | WO2005014541A1 Novel antihypercholesterolemic compound |
| 02/17/2005 | WO2005014540A1 Cyclic amine base-1 inhibitors having a heterocyclic substituent |
| 02/17/2005 | WO2005014539A2 Pyrrole-based hmg-coa reductase inhibitors |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | WO2004002491A8 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 02/17/2005 | US20050038265 Low cost cleaner, stripper, solvent |
| 02/17/2005 | US20050038264 Production of N-aryl-2-lactam and N-cycloalkyl-2-lactam by reductive amination of lactones with aryl amines |
| 02/17/2005 | US20050038263 efficient and low cost process for the production of aryl, alkyl and cycloalkyl pyrrolidones |
| 02/17/2005 | US20050038256 Synthetic process for trans-aminocyclohexyl ether compounds |
| 02/17/2005 | US20050038248 Chemotherapeutic agents |
| 02/17/2005 | US20050038242 Pyrrolothiazine and pyrrolothiazephine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 02/17/2005 | US20050038212 emulsion; ethylene or other 1-olefins; catalyst complex of nickel or palladium and a salicylaldehyde derivative with an aminopyrrolidine; high activity; highly crystalline polyethylene; narrow molecular weight distribution |
| 02/17/2005 | US20050038081 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide |
| 02/17/2005 | US20050038072 Nitrogeneous cyclic ketone derivative, process for producing the same, and use |
| 02/17/2005 | US20050038035 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 02/17/2005 | US20050038028 Hydroxyethylene compounds with asp2 inhibitory activity |
| 02/17/2005 | US20050038021 2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 02/17/2005 | US20050038020 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods |
| 02/17/2005 | US20050038008 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |